![](https://i.kinja-img.com/gawker-media/image/upload/s--hUU4Mjd---/c_fit,fl_progressive,q_80,w_636/1ce5d75c9028be7cd8a247bcbe117385.jpg)
In a study out this week, scientists describe a novel experimental pill that may be able to help patients with a difficult-to-treat form of leukemia. Nearly half of patients in the Phase I trial responded to the treatment, called revumenib, while about a third experienced a complete remission of their cancer. More…